• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌骨转移的外科治疗。

Surgery for skeletal metastases in lung cancer.

机构信息

Department of Molecular Medicine and Surgery, Section of Orthopaedics and Sports Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.

出版信息

Acta Orthop. 2011 Feb;82(1):96-101. doi: 10.3109/17453674.2011.552779. Epub 2011 Feb 1.

DOI:10.3109/17453674.2011.552779
PMID:21281260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3230004/
Abstract

BACKGROUND AND PURPOSE

Most lung cancer patients with skeletal metastases have a short survival and it is difficult to identify those patients who will benefit from palliative surgery. We report complication and survival rates in a consecutive series of lung cancer patients who were operated for symptomatic skeletal metastases.

METHODS

This study was based on data recorded in the Karolinska Skeletal Metastasis Register. The study period was 1987-2006. We identified 98 lung cancer patients (52 females). The median age at surgery was 62 (34-88) years. 78 lesions were located in the femur or spine.

RESULTS

The median survival time after surgery was 3 (0-127) months. The cumulative 12-month survival after surgery was 13% (95% CI: 6-20). There was a difference between the survival after spinal surgery (2 months) and after extremity surgery (4 months) (p = 0.03). Complete pathological fracture in non-spinal metastases (50 patients) was an independent negative predictor of survival (hazard ratio (HR) = 1.8, 95% CI: 1-3). 16 of 31 patients with spinal metastases experienced a considerable improvement in their neurological function after surgery. The overall complication rate was 20%, including a reoperation rate of 15%.

INTERPRETATION

Bone metastases and their subsequent surgical treatment in lung cancer patients are associated with high morbidity and mortality. Our findings will help to set appropriate expectations for these patients, their families, and surgeons.

摘要

背景与目的

大多数患有骨骼转移的肺癌患者生存时间较短,难以确定哪些患者将从姑息性手术中获益。我们报告了一系列连续的肺癌患者因骨骼转移所致症状而行手术治疗的并发症和生存率。

方法

本研究基于 Karolinska 骨骼转移登记处记录的数据。研究期间为 1987 年至 2006 年。我们确定了 98 例肺癌患者(52 例女性)。手术时的中位年龄为 62 岁(34-88 岁)。78 处病变位于股骨或脊柱。

结果

手术后的中位生存时间为 3 个月(0-127 个月)。手术后 12 个月的累积生存率为 13%(95%CI:6-20)。脊柱手术后的生存时间(2 个月)与四肢手术后的生存时间(4 个月)存在差异(p = 0.03)。非脊柱转移灶完全病理性骨折(50 例)是生存的独立负预测因素(危险比(HR)= 1.8,95%CI:1-3)。31 例脊柱转移患者中有 16 例在手术后神经功能显著改善。总体并发症发生率为 20%,包括再手术率为 15%。

结论

肺癌患者的骨骼转移及其随后的手术治疗与高发病率和死亡率相关。我们的研究结果将有助于为这些患者、他们的家人和外科医生设定适当的预期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18f1/3230004/b0e05cb4fc3e/ORT-0300-9734-082-096_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18f1/3230004/b0e05cb4fc3e/ORT-0300-9734-082-096_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18f1/3230004/b0e05cb4fc3e/ORT-0300-9734-082-096_g001.jpg

相似文献

1
Surgery for skeletal metastases in lung cancer.肺癌骨转移的外科治疗。
Acta Orthop. 2011 Feb;82(1):96-101. doi: 10.3109/17453674.2011.552779. Epub 2011 Feb 1.
2
Factors Affecting Survival in Patients Undergoing Palliative Spine Surgery for Metastatic Lung and Hepatocellular Cancer: Dose the Type of Surgery Influence the Surgical Results for Metastatic Spine Disease?影响转移性肺癌和肝癌患者姑息性脊柱手术生存的因素:手术类型是否会影响转移性脊柱疾病的手术结果?
Clin Orthop Surg. 2015 Sep;7(3):344-50. doi: 10.4055/cios.2015.7.3.344. Epub 2015 Aug 13.
3
Complications of spine surgery for metastasis.脊柱转移瘤手术的并发症
Eur J Orthop Surg Traumatol. 2020 Jan;30(1):37-56. doi: 10.1007/s00590-019-02541-0. Epub 2019 Aug 31.
4
[A surgical method in the complex treatment of metastatic bone tumors].[一种转移性骨肿瘤综合治疗中的手术方法]
Khirurgiia (Mosk). 1992 Jul-Aug(7-8):59-63.
5
Surgery of skeletal metastases in 306 patients with prostate cancer.306 例前列腺癌患者骨骼转移的外科治疗。
Acta Orthop. 2012 Feb;83(1):74-9. doi: 10.3109/17453674.2011.645197. Epub 2011 Dec 29.
6
Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases.282例因胸腰椎转移瘤导致神经功能缺损而接受手术治疗患者的生存情况、并发症及预后
Eur Spine J. 2006 Feb;15(2):196-202. doi: 10.1007/s00586-004-0870-6. Epub 2005 Mar 3.
7
Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients.脊柱和四肢转移瘤手术后的生存率。241例患者的预后评估。
Acta Orthop Scand. 1995 Apr;66(2):143-6. doi: 10.3109/17453679508995508.
8
Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study.形态计量分析在肺癌脊柱转移患者中的应用:一项临床研究。
Neurosurg Focus. 2016 Aug;41(2):E12. doi: 10.3171/2016.5.FOCUS16152.
9
Skeletal metastases in 301 breast cancer patients: patient survival and complications after surgery.301例乳腺癌患者的骨转移:手术患者的生存情况及并发症
Breast. 2014 Jun;23(3):286-90. doi: 10.1016/j.breast.2014.02.012. Epub 2014 Mar 27.
10
Decompression surgery for spinal metastases: a systematic review.脊柱转移瘤减压手术:一项系统综述
Neurosurg Focus. 2016 Aug;41(2):E2. doi: 10.3171/2016.6.FOCUS16166.

引用本文的文献

1
Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with -mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.股骨骨转移是表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)治疗的伴有突变的非小细胞肺癌患者的不良预后因素:一项回顾性多中心队列研究。
Ther Adv Med Oncol. 2024 Dec 20;16:17588359241303090. doi: 10.1177/17588359241303090. eCollection 2024.
2
Bone metastases in non-small cell lung cancer: a narrative review.非小细胞肺癌中的骨转移:一篇叙述性综述
J Thorac Dis. 2022 May;14(5):1696-1712. doi: 10.21037/jtd-21-1502.
3
Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: A retrospective analysis of 140 patients.

本文引用的文献

1
Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates.肺癌伴骨转移患者的骨骼并发症:强调需要早期诊断和使用双膦酸盐治疗。
Lung Cancer. 2010 Jan;67(1):4-11. doi: 10.1016/j.lungcan.2009.08.020.
2
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
3
Predictors of survival in patients with bone metastasis of lung cancer.肺癌骨转移患者生存的预测因素。
四肢及骨盆骨转移瘤手术后的疗效及预后因素:140例患者的回顾性分析
J Bone Oncol. 2022 Apr 6;34:100427. doi: 10.1016/j.jbo.2022.100427. eCollection 2022 Jun.
4
Surgical outcomes of metastatic bone tumors in the extremities (Surgical outcomes of bone metastases).四肢转移性骨肿瘤的手术结果(骨转移的手术结果)
J Bone Oncol. 2021 Feb 19;27:100352. doi: 10.1016/j.jbo.2021.100352. eCollection 2021 Apr.
5
Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.Nm23-H1 通过上调 miR-660-5p 靶向的 SMARCA5 抑制肺癌骨特异性转移。
Thorac Cancer. 2020 Mar;11(3):640-650. doi: 10.1111/1759-7714.13308. Epub 2020 Feb 5.
6
Macrophage Origin, Metabolic Reprogramming and IL-1 Signaling: Promises and Pitfalls in Lung Cancer.巨噬细胞起源、代谢重编程与白细胞介素-1信号传导:肺癌中的前景与陷阱
Cancers (Basel). 2019 Mar 2;11(3):298. doi: 10.3390/cancers11030298.
7
Surgical results and clinical risks of postoperative complications in patients with painful malignant spinal cord compression after decompressive surgery.减压手术后疼痛性恶性脊髓压迫症患者的手术结果及术后并发症的临床风险
J Pain Res. 2018 Aug 29;11:1679-1687. doi: 10.2147/JPR.S162435. eCollection 2018.
8
Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine.长骨和脊柱转移性癌症疾病的诊断算法、预后因素及外科治疗
EFORT Open Rev. 2017 Sep 1;2(9):372-381. doi: 10.1302/2058-5241.2.170006. eCollection 2017 Sep.
9
Effect of synchronous solitary bone metastasectomy and lung cancer resection on non-small cell lung cancer patients.同步孤立性骨转移瘤切除术与肺癌切除术对非小细胞肺癌患者的影响。
Oncol Lett. 2016 Mar;11(3):2266-2270. doi: 10.3892/ol.2016.4190. Epub 2016 Feb 8.
10
Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer.非小细胞肺癌所致有症状的转移性脊髓压迫患者术后生存预后的预测
BMC Cancer. 2015 Nov 5;15:853. doi: 10.1186/s12885-015-1852-2.
Clin Orthop Relat Res. 2008 Mar;466(3):729-36. doi: 10.1007/s11999-007-0051-0. Epub 2008 Jan 3.
4
Patient survival after surgery for osseous metastases from renal cell carcinoma.肾细胞癌骨转移手术后的患者生存率。
J Bone Joint Surg Am. 2007 Aug;89(8):1794-801. doi: 10.2106/JBJS.F.00603.
5
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.单独使用紫杉醇-卡铂或联合贝伐单抗治疗非小细胞肺癌。
N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884.
6
Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.厄洛替尼用于晚期非小细胞肺癌一线治疗:一项II期研究。
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6049-55. doi: 10.1158/1078-0432.CCR-06-0260.
7
Long-term survival cases of lung cancer presented as solitary bone metastasis.以孤立性骨转移为表现的肺癌长期生存病例。
Ann Thorac Cardiovasc Surg. 2005 Dec;11(6):401-4.
8
Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail?股骨近端骨转移性病变的外科治疗:内置假体还是重建钉?
J Bone Joint Surg Br. 2005 Dec;87(12):1653-7. doi: 10.1302/0301-620X.87B12.16629.
9
Preventing the lung cancer epidemic.预防肺癌流行。
Ann Oncol. 2005 Oct;16(10):1565-6. doi: 10.1093/annonc/mdi328.
10
Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care.因病理性骨折接受手术患者的生存情况:对临终骨科护理的启示
J Clin Oncol. 2005 Sep 1;23(25):6072-82. doi: 10.1200/JCO.2005.08.104.